A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma

• Published in: Acta dermato-venereologica 2022-09, Vol.102, p.adv00773-adv00773
• Main Authors: Luherne, Camille, Menguy, Sarah, Ferte, Thomas, Beylot-Barry, Marie, Seneschal, Julien, Milpied, Brigitte, Vial, Jean-Philippe, Gros, Audrey, Amintas, Samuel, Vergier, Béatrice, Pham-Ledard, Anne
• Format: Article
• Language: English
• Subjects: erythrodermic drug-induced erythroderma; erythrodermic eczema; erythrodermic mycosis fungoides; erythrodermic psoriasis; Original; programmed-death 1; Sézary syndrome
• ISSN: 0001-5555; 1651-2057
• DOI: 10.2340/actadv.v102.1062

Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with erythroderma, 21 were diagnosed with eczema, 17 with psoriasis, 20 with drug-induced erythroderma, 13 with erythrodermic mycosis fungoides and 20 with Sézary syndrome. Nail alterations, ear involvement, and severe scaling were significantly associated with psoriasis (p = 0.044). Fever and hypereosinophilia were associated with drug-induced erythroderma. Expression of programmed cell death protein 1 was observed in all skin biopsies. However, with Sézary syndrome, programmed cell death protein 1 expression was significantly higher than with other aetiologies. A programmed cell death protein 1 hormone receptor score (H-score) >50 was associated with Sézary syndrome (p